Nat Commun. 2026 Apr 20.doi: 10.1038/s41467-026-72181-6. (IF:15.7).

中文速读

本研究使用Engreen的Entranster-in vivo试剂将UCNPs-PEI@paCas13d系统递送至小鼠骨组织,通过近红外光激活实现TET3基因的RNA敲低,用于治疗激素相关性骨坏死。

小鼠骨MLO-Y4

本文使用:长核酸转染试剂Entranster™-H4000

阅读完整中文解读 →

查看产品详情(含全部 119 篇文献) →

Photoactivatable CRISPR/Cas13d via upconversion nanoparticles for deep tissue RNA engineering and orthopedic therapy

Affiliations

Affiliations

  • 1 Department of Orthopedic, Tianjin Hospital, Tianjin University, Tianjin, China.
  • 2 Department of Bone and Soft Tissue Oncology, Tianjin Hospital, Tianjin University, Tianjin, China.
  • 3 Tianjin Key Laboratory of Orthopedic Biomechanics and Medical Engineering, Tianjin Hospital, Tianjin, China.
  • 4 Tianjin Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, School of Medicine, Nankai University, Tianjin, China. junjiao@nankai.edu.cn.
  • 5 Department of Radiology, Tianjin Key Lab of Functional Imaging & Tianjin Institute of Radiology, Tianjin Medical University General Hospital, Tianjin, China. panjinbin@tmu.edu.cn.
  • 6 Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. panjinbin@tmu.edu.cn.
  • 7 Department of Orthopedic, Tianjin Hospital, Tianjin University, Tianjin, China. maxinlong8686@yeah.net.
  • 8 Tianjin Key Laboratory of Orthopedic Biomechanics and Medical Engineering, Tianjin Hospital, Tianjin, China. maxinlong8686@yeah.net.
# Contributed equally.

Free article

Abstract

Spatiotemporal control of RNA therapeutics remains a fundamental challenge limiting clinical translation. Here, we develop a photoactivatable CRISPR/Cas13d (paCas13d) system that enables non-invasive, light-controlled RNA manipulation in deep tissues. Through structure-guided engineering, we identify optimal split sites within RfxCas13d and create light-switchable fragments using CRY2PHR/CIBN optogenetic dimerization. To overcome the limited tissue penetration of blue light, we engineer polyethylenimine-functionalized upconversion nanoparticles (UCNPs-PEI) that serve dual roles as gene carriers and photon transducers, converting tissue-penetrating near-infrared (NIR) to blue light. The UCNPs-PEI@paCas13d system achieves precise spatiotemporal control of RNA targeting within bone tissue in vivo. In a murine steroid-associated osteonecrosis model, NIR-activated paCas13d achieves robust TET3 knockdown, disrupting the TET3-5hmC-PTEN axis that drives glucocorticoid-induced osteocyte apoptosis. This targeted intervention prevents bone deterioration, with treated mice showing preserved trabecular architecture, enhanced bone volume, and favorable shifts in bone turnover markers, while maintaining systemic glucocorticoid efficacy. Our platform combines the programmability of CRISPR/Cas13d with non-invasive optical control, offering a versatile approach for treating diseases requiring localized RNA modulation while minimizing systemic effects.

阅读本文的中文解读 →

本文使用的产品

长核酸转染试剂Entranster™-H4000

已有 119 篇已发表文献

查看产品详情(含全部 119 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单